Peptide PT-141, or bremelanotide, is FDA-approved for low sexual desire in premenopausal women. Learn uses, dosage, safety, and legal status.
PT-141 peptide, also known as bremelanotide, is a prescription melanocortin receptor agonist that is FDA-approved under the brand name Vyleesi for hypoactive sexual desire disorder (HSDD) in premenopausal women. It is not approved for men, and it is not a general sexual enhancer or a legal over-the-counter peptide. PT-141 works on the central nervous system rather than on blood flow, which makes it different from medications like sildenafil (Viagra).
What Is PT-141 Peptide and How Does It Work?
PT-141 is a synthetic cyclic peptide that activates melanocortin receptors, especially MC4R, in the brain. This activation is believed to influence sexual desire and arousal pathways. Unlike PDE5 inhibitors that primarily increase blood flow to the genitals, PT-141 acts centrally.
The FDA approved bremelanotide in 2019 as Vyleesi for premenopausal women with acquired, generalized HSDD. It is not approved for postmenopausal women, men, or anyone seeking a recreational libido boost.
Researchers originally studied an intranasal formulation, but the approved product is a subcutaneous injection. That distinction matters because compounded versions are not FDA-approved.
PT-141 is sometimes confused with Melanotan II, another melanocortin peptide. Melanotan II is not FDA-approved for any use, and it is sold illegally for tanning. PT-141 and Melanotan II are not the same product, even though they share a similar mechanism.
The half-life of bremelanotide is roughly 2.7 hours, so its effects are not long-lasting. That short window is one reason dosing is timed around anticipated activity.
FDA-Approved Use vs. Off-Label Use
PT-141 has one narrow approved indication and a much broader set of off-label uses. The table below summarizes the difference.
| Category | FDA-Approved Use | Common Off-Label Use |
|---|---|---|
| Population | Premenopausal women with HSDD | Men with erectile dysfunction or low desire |
| Formulation | Subcutaneous injection (Vyleesi) | Compounded injections, nasal sprays, or troches |
| Regulatory status | Approved and regulated | Not FDA-approved; compounded products are unregulated |
| Evidence | Randomized trials support modest benefit | Limited, mostly small or anecdotal |
Interest in pt-141 peptide for men is growing, but no large, FDA-reviewed trials support routine use in men. Some clinicians prescribe it off-label, but that decision requires a careful risk-benefit discussion.
PT-141 Dosage and Forms
The approved dose of bremelanotide is 1.75 mg injected subcutaneously into the abdomen or thigh. It should be taken at least 45 minutes before anticipated sexual activity, and no more than one dose in 24 hours or eight doses per month.
Dosing for off-label use is not standardized. A pt-141 peptide dosage chart for men often lists 1.75 mg to 10 mg, but those numbers come from small studies or online forums, not from FDA labeling.
| Form | Typical Dose | Frequency | Status |
|---|---|---|---|
| Subcutaneous injection (Vyleesi) | 1.75 mg | As needed, max once per 24 hours, max 8 doses per month | FDA-approved for premenopausal women with HSDD |
| Intranasal spray | 10 mg (studied) | Not established | Not FDA-approved |
| Compounded injection or troche | Varies (often 1.75-10 mg) | Varies | Not FDA-approved |
A pt-141 peptide nasal spray is not FDA-approved; the approved product is a subcutaneous injection. Compounded nasal sprays may contain different amounts than labeled, which raises safety concerns.
Safety, Side Effects, and Legal Status
Common side effects of bremelanotide include nausea, flushing, headache, and injection site reactions. It can also cause a transient increase in blood pressure, so it is contraindicated in people with uncontrolled hypertension or known cardiovascular disease. Repeated use may cause darkening of the skin, gums, or other areas.
PT-141 is a prescription drug in the United States. It is illegal to buy prescription drugs from unregulated online sources, and products sold as "research chemicals" are not intended for human use.
Reading pt-141 peptide reviews can give you a sense of real-world experiences, but anecdotal reports are not clinical evidence. Always talk with a licensed healthcare provider before using any peptide.
Cost, Access, and What to Avoid
The pt-141 peptide price for brand-name Vyleesi can exceed $1,000 per month without insurance, though manufacturer coupons and some insurance plans may reduce the cost. Compounded versions are often cheaper, but they are not FDA-approved.
A local clinic or telemedicine provider can prescribe PT-141 if appropriate. Verify that any provider is licensed in your state and that the pharmacy is reputable.
You might see online listings that look like a bargain, but Amazon does not sell prescription bremelanotide. Buying from overseas pharmacies carries legal and safety risks, including counterfeit or contaminated products.
Bottom Line
PT-141 (bremelanotide) is a legitimate prescription medication for one specific condition: hypoactive sexual desire disorder in premenopausal women. It is not approved for men, not available over the counter, and not safe to buy from unregulated sellers. If you are considering PT-141, speak with a healthcare professional who can review your health history and legal options.
Frequently Asked Questions
Is PT-141 FDA-approved for men?
No. Bremelanotide (Vyleesi) is only FDA-approved for premenopausal women with hypoactive sexual desire disorder. It is sometimes prescribed off-label to men, but its safety and effectiveness in men have not been established in large clinical trials. A prescription is required in the United States.
How long does PT-141 take to work?
The approved subcutaneous injection is typically given at least 45 minutes before anticipated sexual activity. Effects can last for several hours, but response varies by person. Do not use more than one dose in 24 hours or more than eight doses per month.
Can I buy PT-141 peptide online without a prescription?
No. PT-141 is a prescription drug in the US, and buying it from unregulated websites is illegal and unsafe. Products sold as research chemicals are not for human use and may be counterfeit or contaminated. Talk to a licensed healthcare provider about legal options.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.